Budd-Chiari syndrome: illustrated review of current management.
Budd-Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction at any level from the small hepatic veins to the atriocaval junction. BCS is a complex disease with a wide spectrum of aetiologies and presentations. This article reviews the current literature with respect to presentation, management and prognosis of the disease. Medical, interventional and surgical management of BCS is discussed. Particular attention is paid to interventional and surgical aspects of management. The review is augmented by images, which provide a clinical corollary to the text.
Horton
John D
JD
William Beaumont Army Medical Center, Department of Surgery, El Paso, TX 79920-5001, USA. John.Horton2@amedd.army.mil
San Miguel
Francisco L
FL
Membreno
Fernando
F
Wright
Francis
F
Paima
Juan
J
Foster
Preston
P
Ortiz
Jorge A
JA
D000293:Adolescent; D000328:Adult; D000714:Anastomosis, Surgical; D017130:Angioplasty / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use*; D006502:Budd-Chiari Syndrome / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical / Q000379:methods*; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000379:methods
D000925:Anticoagulants